A company's opening remarks in Q4 FY26 concall: “There are certain years in a company's journey where performance improves, and certain years where the foundation for the next decade is built. For us, FY26 has been one such year where we have built our foundation."

RT @InvestingCanons: Stanley Druckenmiller: “A lot of my style is you [first] build a thesis, hopefully that no one else has built. You sor…

News is focused on which camera brand replaces Hikvision. The more interesting story is who makes the chip inside the camera. Until 2019, that answer was overwhelmingly HiSilicon, Huawei's semiconductor arm that dominated surveillance SoCs globally. US sanctions killed that supply chain overnight and the entire industry moved to Ambarella, Novatek, and Sigmastar. India's CCTV ban accelerates the same logic one layer deeper. Not just who assembles the camera, but who designs the silicon. And that story is already further along than most people realize. L&T Semiconductor Technologies has signed a deal with CP Plus to supply indigenously designed Vision SoCs for 9 million IP cameras over three years. These aren't concept chips. They support 8MP imaging and this is the first time surveillance cameras will be made using chips from an Indian company. CP Plus is the largest domestic brand by market share, so this isn't a token pilot. Beyond L&T Semi, there are at least four more startups building surveillance SoCs under the government's Design Linked Incentive scheme. Mindgrove Technologies has the V2600, a surveillance-grade edge AI chip targeting late 2026 commercial launch. BigEndian Semiconductors raised $3M from Vertex Ventures and partnered with Cadence on Project VASU, a secure-boot SoC with encryption baked into the silicon. 3rdiTech and Netrasemi round out the group. Collectively these four have raised over ₹300 crore and taped out test chips in 2025. Two years ago none of this existed. Now you have five separate Indian chip efforts targeting the same market, with the largest one already locked into a volume manufacturing agreement. India did the same thing in telecom: kicked out Huawei, filled the gap with allied vendors, then started building its own stack with Tejas Networks. Surveillance silicon is following the same script, and hopefully moving faster.

Content and storytelling >>> fundamentals / valuations is peak Substack! If your investment thesis needs a Breaking Bad analogy, you’re not analysing the business, you’re writing fiction. The "TSMC of Niche Pharma" is down 60% from the post and 33% since quoting Walter White.

It was a pleasure to speak at the TIA 20-20 Ideas Summit 2026 at IIT Madras Research Park. Presented my stock pitch on Genesys - a niche business & potential proxy to India's digital infrastructure build-out! Feedback welcome. Thank you @TIA_Investors for the opportunity.

Many are writing off Indian IT by assuming Palantir or AI agents will own these risks: • Governance • Compliance & audit • SLAs, performance, delivery And Enterprises still need someone for orchestration and integration. Indian IT must evolve but it’s far from obsolete.

Our cofounder Sagar Arya dives into the tremendous shift underway in the aerospace industry in this riveting conversation with @ishmohit1 @soicfinance

When you find a company with elite management, structural tailwinds, strong products, fast growth, and ruthless ambition, and you have the ability to track it closely: you don’t nibble. You size up. A 5–10% allocation feels safe today, but becomes a regret in hindsight. These setups don’t come every year. They show up once in a few years. And no, valuations won’t look cheap. When quality is obvious, the edge lies in growth, not multiples.

My investing journey started in 2018 at @TIA_Investors' Bullet Proof Investing event. Almost 8 years later, I’m honoured and excited to be presenting at their 20-20 Ideas Summit!

Kenneth on Metals: “Audacious statement - By 2030, Tata Steel’s balance sheet will be better than India’s largest FMCG firm” youtube.com/live/qkvzEkbmqnA…

Timeless lessons lasted 2 days! 😂 "Nothing new. Same old market lessons - served again."

$700 Mn upfront payment for an Indian drug in Phase 1

We are excited to launch the ithought Equity Research Fellowship, a full-time, nine-month program based in Chennai designed for aspiring equity analysts. Please refer to our LinkedIn post for complete details of the program and application instructions: linkedin.com/posts/ithoughtp…